How does the ER stress-UPR pathway specifically lead to neuronal vulnerability in Gaucher disease?

OPEN

While the study shows ER stress markers (BiP, CHOP) are elevated and correlate with apoptosis, the specific UPR signaling cascades and why neurons are particularly susceptible compared to other cell types remains unclear. This mechanistic gap limits targeted therapeutic development for neuronopathic forms. Gap type: unexplained_observation Source paper: An increase in ER stress and unfolded protein response in iPSCs-derived neuronal cells from neuronopathic Gaucher disease patients. (2024, Scientific reports, PMID:38649404)

Priority: 0.76 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does the ER stress-UPR pathway specifically lead to neuronal vulnerability in Gaucher disease? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does the ER stress-UPR pathway specifically lead to neuronal vulnerability in Gaucher disease? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (4)

ER_STRESSUPRUPRPROTEIN_FOLDINGER STRESSUPRUPRAPOPTOSIS

adjusts (1)

32457508UPR

associated with (1)

RAPAMYCINUPR

induces (1)

32457508UPR

involved in (1)

DAP12UPR

regulate in a tissue-specific manner (1)

35129674UPR

regulates (1)

UPRSYNAPTIC_FUNCTION

senses (1)

32457508UPR

transmits information about (1)

32457508UPR

transmits information about protein folding status to (1)

32457508UPR
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps